These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 30613977

  • 1. Promotion of TRAIL/Apo2L-induced apoptosis by low-dose interferon-β in human malignant melanoma cells.
    Kazaana A, Sano E, Yoshimura S, Makita K, Hara H, Yoshino A, Ueda T.
    J Cell Physiol; 2019 Aug; 234(8):13510-13524. PubMed ID: 30613977
    [Abstract] [Full Text] [Related]

  • 2. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI, Cheriyath V, Jacobs BS, Reu FJ, Borden EC.
    Oncogene; 2008 Jan 17; 27(4):490-8. PubMed ID: 17653094
    [Abstract] [Full Text] [Related]

  • 3. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.
    Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC.
    J Immunol; 2002 Jul 15; 169(2):847-55. PubMed ID: 12097388
    [Abstract] [Full Text] [Related]

  • 4. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
    Chawla-Sarkar M, Leaman DW, Borden EC.
    Clin Cancer Res; 2001 Jun 15; 7(6):1821-31. PubMed ID: 11410525
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.
    Wu XX, Kakehi Y, Mizutani Y, Nishiyama H, Kamoto T, Megumi Y, Ito N, Ogawa O.
    Int J Cancer; 2003 Apr 20; 104(4):409-17. PubMed ID: 12584736
    [Abstract] [Full Text] [Related]

  • 6. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 7. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.
    Leaman DW, Chawla-Sarkar M, Vyas K, Reheman M, Tamai K, Toji S, Borden EC.
    J Biol Chem; 2002 Aug 09; 277(32):28504-11. PubMed ID: 12029096
    [Abstract] [Full Text] [Related]

  • 8. Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
    Bui HTT, Le NH, Le QA, Kim SE, Lee S, Kang D.
    Int J Med Sci; 2019 Aug 09; 16(11):1412-1423. PubMed ID: 31673231
    [Abstract] [Full Text] [Related]

  • 9. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.
    Oishi M, Iizumi Y, Taniguchi T, Goi W, Miki T, Sakai T.
    PLoS One; 2013 Aug 09; 8(2):e55922. PubMed ID: 23431365
    [Abstract] [Full Text] [Related]

  • 10. Increased caspase-2 activity is associated with induction of apoptosis in IFN-beta sensitive melanoma cell lines.
    Kamiya T, Okabayashi T, Yokota S, Kan Y, Ogino J, Yamashita T, Fujii N, Jimbow K.
    J Interferon Cytokine Res; 2010 May 09; 30(5):349-57. PubMed ID: 20187765
    [Abstract] [Full Text] [Related]

  • 11. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.
    Tse AK, Cao HH, Cheng CY, Kwan HY, Yu H, Fong WF, Yu ZL.
    J Invest Dermatol; 2014 May 09; 134(5):1397-1407. PubMed ID: 24213373
    [Abstract] [Full Text] [Related]

  • 12. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH.
    Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875
    [Abstract] [Full Text] [Related]

  • 13. Synergistic antitumor activity of recombinant human Apo2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma.
    Pasello G, Urso L, Silic-Benussi M, Schiavon M, Cavallari I, Marulli G, Nannini N, Rea F, Ciminale V, Favaretto A.
    J Thorac Oncol; 2014 Jul 15; 9(7):1008-1017. PubMed ID: 24922007
    [Abstract] [Full Text] [Related]

  • 14. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 15. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
    Nguyen DM, Yeow WS, Ziauddin MF, Baras A, Tsai W, Reddy RM, Chua A, Cole GW, Schrump DS.
    Cancer J; 2006 Jul 15; 12(4):257-73. PubMed ID: 16925970
    [Abstract] [Full Text] [Related]

  • 16. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
    Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, Lee D, von Goetz M, Yee SF, Totpal K, Huw L, Katta V, Cavet G, Hymowitz SG, Amler L, Ashkenazi A.
    Nat Med; 2007 Sep 15; 13(9):1070-7. PubMed ID: 17767167
    [Abstract] [Full Text] [Related]

  • 17. Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade.
    Reddy RM, Yeow WS, Chua A, Nguyen DM, Baras A, Ziauddin MF, Shamimi-Noori SM, Maxhimer JB, Schrump DS, Nguyen DM.
    Apoptosis; 2007 Jan 15; 12(1):55-71. PubMed ID: 17136498
    [Abstract] [Full Text] [Related]

  • 18. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.
    Liu Y, Hawkins OE, Vilgelm AE, Pawlikowski JS, Ecsedy JA, Sosman JA, Kelley MC, Richmond A.
    Clin Cancer Res; 2015 Dec 01; 21(23):5338-48. PubMed ID: 26152738
    [Abstract] [Full Text] [Related]

  • 19. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 01; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 20. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
    Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM.
    Int J Cancer; 2002 Jun 01; 99(4):491-504. PubMed ID: 11992538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.